Article
Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy.
The Journal of infectious diseases - 15 Jun 2004
Cavert Winston, Webb Chui-Ho, Balfour Henry H
Abstract excerpt
The C terminus of the human immunodeficiency virus type 1 (HIV-1) accessory protein vpr acts in viral cell cycle arrest, nuclear localization, and apoptosis. Polymorphisms in this region are described in series of long-term nonprogression cases. We determined vpr sequences of archived baseline specimens from 96 participants in a historical trial of single- versus double-nucleoside reverse-transcriptase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
